Cost-effectiveness of natalizumab in patients with Crohn's disease who have failed Anti-TNFα therapy

被引：0
|
作者：
Sands, Bruce
Wolf, Douglas
Panjabi, Sumeet
Niecko, Timothy
Hass, Steven
Lacey, Loretto
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Atlanta Gastroenterol Associates, Atlanta, GA USA
[4] Elan Pharmaceut Inc, San Francisco, CA USA
[5] LLC, Niecko Hlth Econ, Escondido, CA USA
[6] Elan Pharmaceut Ltd, Pharmacoecon, Dublin, Ireland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1025
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [31] Efficacy assessment of natalizumab in patients with Crohn's disease and prior history of anti-TNF therapy: Results from ENACT-1
    Sandborn, WJ
    Colombel, JF
    Enns, R
    Feagan, B
    Hanauer, SB
    Lawrance, I
    Panaccione, R
    Sanders, M
    Schreiber, S
    Targan, SR
    van Deventer, SJ
    Rutgeerts, P
    GASTROENTEROLOGY, 2004, 126 (04) : A76 - A76
  • [32] Anti-TNF treatment of Crohn's disease
    Camoglio, L
    VanDeventer, SJH
    Tytgat, GNJ
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 111 - 117
  • [33] Anti-TNF antibodies for Crohn's disease
    Camilleri, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1662 - 1662
  • [34] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [35] Natalizumab is Effective in the Treatment of Moderate to Severe Crohn's Disease Unresponsive to Anti-TNFα Agents
    Elvanides, Harry S.
    Burchett, Mary
    Ingram, Karen R.
    Annis, Kim
    Arsenescu, Razvan I.
    de Villiers, Willem J.
    GASTROENTEROLOGY, 2010, 138 (05) : S698 - S698
  • [36] Corticosteroid avoidance in patients with crohn's disease who are newly initiated to therapy with an anti-TNF agent versus azathioprine
    Kane, Sunanda
    Hassig, Tanna
    Malpas, Phyllis
    Pennington, KellyAnne
    Smith, Teak
    Hicks, Rachel Velvet
    Dowdle, Merriman
    Jaganathan, Srihari
    Horst, Sara
    Schwartz, David A.
    PHARMACOTHERAPY, 2013, 33 (10): : E253 - E253
  • [37] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
  • [38] Anti-TNF induction and maintenance therapy for refractory Crohn's disease
    Hartnell, F. L.
    Radford-Smith, G.
    Jones, L.
    Sewell, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 62
  • [39] Impact analysis of expanding anti-TNF therapy for Crohn's disease
    Honeycutt, Amanda
    Breck, Andrew
    Bass, Sarah
    Esposito, Dominick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (02) : 79 - 88
  • [40] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
    Rezik, Mohamed
    Mattina, Deirdre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
12345